Eshana Shah

Eshana Shah, MD is a Clinical Assistant Professor in the Department of Hematology and Oncology at the University of Washington School of Medicine and Assistant Professor in the Clinical Research Division at Fred Hutchinson Cancer Center. She practices at Fred Hutchinson Cancer Center - South Lake Union as a Physician specializing in adult blood and marrow transplantation and immunotherapy.

• M.D. from University of Wisconsin School of Medicine and Public Health (2012)
• B.A. from University of Chicago (2006)
• Residency in Internal Medicine at University of Wisconsin Hospitals and Clinics
• Fellowship in Hematology and Oncology at University of Illinois
• Board Certified in Medical Oncology (2023) and Hematology (2022) by American Board of Internal Medicine

Dr. Shah's research focuses on health disparities across individual and community levels affecting blood cancer outcomes. Her work combines quantitative analysis of survival and complications with patient interviews to understand treatment barriers. Key research areas include equitable treatment access, patient experience mapping, and intervention design for blood cancer care delivery. She actively investigates immunotherapy applications and transplantation outcomes through clinical trials at Fred Hutch.

Her publication record spans molecular oncology (SH2 domain studies), lymphoma pathology, immunotherapy toxicity, and health disparities research. Recent work emphasizes Hodgkin lymphoma biomarkers (2024), immune-related hepatitis mechanisms (2023), and intestinal T-cell lymphoma diagnostics (2022), showing consistent focus on hematologic malignancies and treatment complications.

As part of Fred Hutch's multidisciplinary care team, Dr. Shah collaborates with patient care coordinators, nurses, dietitians, and social workers to provide comprehensive cancer care. Her clinical work directly informs research on mitigating treatment barriers for underserved populations.